Remus Pharmaceuticals Ltd

NSE: REMUS · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹946.00
Market cap: ₹1,115 Cr
Revenue (annual): ₹853.6 Cr
Net profit (annual): ₹36.99 Cr
P/E (TTM): 30.1×Sector 50.4×
Promoter holding: 70.95%
FII holding: 5.28%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All SME to Main Board Migration 1 Merger & Restructuring 1 Management Change 1 Dividend 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

7 Sep 2026 21:00 IST NSE

Dividend

Remus Pharmaceuticals Dividend

Remus Pharmaceuticals Limited has fixed September 22, 2026, as the record date for determining shareholder entitlement to a final dividend of Rs. 0.50 per share.

Read the filing ↗